Illumina CLIA lab subscribes to Clarity LIMS to augment existing informatics infrastructure
News Mar 03, 2013
GenoLogics Life Science Software, a leading provider of laboratory information management systems (LIMS) designed for today's omics labs, has announced that the Illumina Clinical Services Laboratory has signed a subscription license agreement for Clarity LIMS. Under the agreement, Clarity LIMS, alongside internally developed systems within the CLIA-certified, CAP-accredited laboratory at Illumina, will be used to support Illumina's TruSight Individual Genome Sequencing (IGS) test.
"In the clinical laboratory environment, informatics tools to support compliance, such as the data and workflow enforcement features offered in Clarity LIMS, are crucial to ensuring high quality throughout the laboratory process," said Marc Laurent, Director of Commercial Services for Illumina. "We are confident that Clarity LIMS will help us to maintain our high quality standards and serve physicians and patients as the demand for our sequencing services grow."
Clarity LIMS is an intuitive lab management system that combines information management essentials for CLIA-certified and other regulated labs with a clear and simple interface. Specifically, Clarity LIMS assists these organizations with workflow enforcement, adherence to standard operating procedures and management of the specific complexities associated with next-generation sequencing (NGS). All of these capabilities can be implemented within a few weeks, making Clarity LIMS unparalleled in the industry.
"We are pleased to be part of the Illumina CLIA laboratory's' robust informatics ecosystem," says Michael Ball, CEO of GenoLogics. "An increasing number of CLIA laboratories are taking advantage of our flexible Clarity LIMS subscription licensing to support the growing sequencing services business."
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
The architecture of each person’s brain is unique, and differences may influence how quickly people can complete various cognitive tasks.o learn more, scientists are developing a new tool — computational models of the brain — to simulate how the structure of the brain may impact brain activity and, ultimately, human behavior.READ MORE